Takeda Pharmaceutical Company Limited Proceeds From Issue Of Bonds Notes And Debentures
Takeda Pharmaceutical Company Limited (TAK) reported Proceeds From Issue Of Bonds Notes And Debentures of JPY 934.46 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfBondsNotesAndDebentures · last filed 2025-06-25
| Period end | Proceeds From Issue Of Bonds Notes And Debentures 12 month |
|---|---|
| 2025-03-31 | 934.46B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 75.00B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 249.33B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 1.18T JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 496.19B JPY 20-F · filed 2020-06-24 |
| 2019-03-31 | 1.58T JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 56.30B JPY 20-F · filed 2019-06-27 |